Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Renishaw plc is a British engineering and scientific technology company headquartered in Wotton-under-Edge, Gloucestershire, England, specializing in precision measurement and healthcare solutions. Founded in 1973 by Sir David McMurtry and John Deer, it pioneered the touch-trigger probe for coordinate-measuring machines, revolutionizing precision metrology for delicate components in industries like aerospace and manufacturing. The company develops advanced products including touch probes for CNC machine tools, calibration systems, linear and rotary encoders, additive manufacturing machines for metal 3D printing, dental CAD/CAM systems, Raman spectroscopy equipment, and medical devices for functional neurosurgery. Renishaw plc operates globally with 67 locations across 36 countries and over 5,000 employees, focusing on innovation in metrology, motion control, healthcare, spectroscopy, and industrial automation. Its technologies enhance efficiency in manufacturing sectors such as transport, agriculture, and electronics, while advancing healthcare applications, establishing it as a FTSE 250 constituent and leader in high-precision engineering.
£50.50
+£1.42 (+2.89%)
EOD Jul 3, 2026
15.13% operating margin is respectable but not wide. ROIC at 8.25%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 3.1%, steady but not accelerating.
At 44x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
43.8x earnings, 40.2x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£713M
▲ +3.1% YoY
Net Income (TTM)
£84M
▼ -13.6% YoY
Op. Margin
15.13%
▼ -0.6pp YoY
ROIC
8.25%
▼ -1.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
£91M
▲ +85.3% YoY
Op. Cash Flow (TTM)
£133M
▲ +51.1% YoY
Net Debt
-£258M
Net Cash Position
Cash & Equiv.
£274M
3Y CAGR: +2.0%
3Y CAGR: +3.7%
Continue Research
At a P/E of 43.8 and a price-to-free-cash-flow of 40.2, Renishaw (RSW.XLON) trades above a two-stage DCF intrinsic value of about £25.31 per share, so at £50.50 the stock looks overvalued (49.9% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Renishaw scores 47/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 1.5%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about £25.31 per share for RSW.XLON, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around £18.99. At today's £50.50, that puts the stock about 49.9% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Renishaw scores 47 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 15.1% operating margin and a 8.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Renishaw pays a regular dividend of about £0.76 per share per year (typically in quarterly installments), a yield of roughly 1.5% at the current price. That is a payout ratio of about 66.2% of earnings, so the dividend is covered, with less cushion. Renishaw has grown the dividend at roughly 52.7% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For RSW.XLON's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. RSW.XLON currently trades above its estimated intrinsic value and scores 47/100 on quality (mixed). It also yields about 1.5%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.